Key terms
About EGRX
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EGRX news
Apr 15
9:38am ET
Eagle Pharmaceuticals says unlikely to file Form 10-Q or 10-K by May 13
Apr 15
7:11am ET
Eagle Pharmaceuticals to present data from Phase III trial of amisulpride
Apr 12
4:34pm ET
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
Mar 11
10:02am ET
Eagle Pharmaceuticals discloses resignation of CFO Brian Cahill
Mar 08
5:03pm ET
Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
Feb 13
9:02am ET
Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline
Jan 19
3:04am ET
Eagle Pharmaceuticals Updates Bendamustine IP Portfolio
Jan 18
6:53am ET
Eagle provides update on bendamustine intellectual property portfolio
No recent press releases are available for EGRX
EGRX Financials
Key terms
Ad Feedback
EGRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
EGRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
